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Abstract
Introduction We conducted a study to evaluate the incidence,
risk factors and outcomes associated with early acute kidney
injury (AKI) in sepsis.
Methods The study was a retrospective interrogation of
prospectively collected data from the Australian New Zealand
Intensive Care Society Adult Patient Database. Data were
collected from 57 intensive care units (ICUs) across Australia. In
total, 120,123 patients admitted to ICU for more than 24 hours
from 1 January 2000 to 31 December 2005 were included in
the analysis. The main outcome measures were clinical and
laboratory data and outcomes.
Results Of 120,123 patients admitted, 33,375 had a sepsis-
related diagnosis (27.8%). Among septic patients, 14,039
(42.1%) had concomitant AKI (septic AKI). Sepsis accounted
for 32.4% of all patients with AKI. For septic AKI stratified by
RIFLE (risk of renal failure, injury to the kidney, failure of kidney
function, loss of kidney function and end-stage kidney disease)
category, 38.5% of patients belonged to the risk category,
38.8% to the injury category and 22.7% to the failure category.
Septic AKI patients had greater acuity of illness (P < 0.0001),
lower blood pressure (P < 0.0001), higher heart rates (P <
0.0001), worse pulmonary function measures by arterial oxygen
tension/fraction of inspired oxygen ratio (P < 0.0001), greater
acidaemia (P  < 0.0001) and higher white cell counts (P  <
0.0001) compared with patients with nonseptic AKI. Septic AKI
was also associated with greater severity of AKI (RIFLE category
injury or failure) compared with nonseptic AKI. Septic AKI was
associated with a significantly higher crude and co-variate
adjusted mortality in the ICU (19.8% versus 13.4%; odds ratio
1.60, 95% confidence interval 1.5 to 1.7; P < 0.001) and in
hospital (29.7% versus 21.6%; odds ratio 1.53, 95%
confidence interval 1.46 to 1.60; P < 0.001) compared with
nonseptic AKI. Septic AKI was associated with higher ICU and
hospital mortality across all strata of RIFLE categories. Septic
AKI patients had longer durations of stay in both ICU and
hospital across all strata of RIFLE categories.
Conclusion Septic AKI is common during the first 24 hours
after ICU admission. Patients with septic AKI are generally
sicker, with a higher burden of illness, and have greater
abnormalities in acute physiology compared with patients with
nonseptic AKI. Moreover, septic AKI is independently
associated with higher odds of death and longer duration of
hospitalization.
Introduction
Acute kidney injury (AKI) is a common clinical problem in inten-
sive care unit (ICU) patients and independently predicts poor
outcome [1-4]. Recently, two large multicentre cohort studies
[5,6] reported the occurrence of AKI in an estimated 36% of
ADQI = Acute Dialysis Quality Initiative; AKI = acute kidney injury; ANZICS = Australian and New Zealand Intensive Care Society; APACHE = Acute 
Physiology and Chronic Health Evaluation; APD = Adult Patient Database; CI = confidence interval; FiO2 = fraction of inspired oxygen; ICU = intensive 
care unit; MDRD = Modification of Diet in Renal Disease; OR = odds ratio; PaO2 = arterial oxygen tension; RIFLE = risk of renal failure, injury to the 
kidney, failure of kidney function, loss of kidney function and end-stage kidney disease; SAPS = Simplified Acute Physiology Score.Critical Care    Vol 12 No 2    Bagshaw et al.
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all patients admitted to the ICU. Moreover, additional observa-
tional data indicate that the incidence of AKI is rising [7,8].
This large and increasing burden of AKI has in part been attrib-
uted to shifts in patient demographics (older, more co-morbid
illness), severity of illness (multiple organ dysfunction syn-
drome) and AKI associated with complex interventions (organ
transplantation) [9,10]. Consequently, the aetiology of AKI in
critically ill patients is often multifactorial. However, sepsis has
consistently been found to be a leading contributing factor to
AKI in critical illness [11-18]. Discriminating between AKI of
septic and nonseptic origin may have clinical relevance [19].
Evolving data suggest that septic AKI may be characterized by
a distinct pathophysiology [9,20-22]. For that reason, septic
AKI may be associated with important differences in terms of
patient characteristics, response to interventions and clinical
outcomes when compared with nonseptic precipitants of AKI.
Regrettably, to date, relatively few studies have focused on
describing the epidemiology of septic AKI in critically ill
patients [12-18]. Two multicentre studies [12,15] have shown
that 46% to 48% of all AKI in critically ill patients can be attrib-
uted to sepsis [12,15]. Alternatively, those studies primary
focused on sepsis have described that an estimated 10% to
50% of patients develop AKI [13,14,16-18].
Accordingly, in view of the relatively limited data available on
septic AKI and its likely importance, we interrogated the Aus-
tralian and New Zealand Intensive Care Society (ANZICS)
Adult Patient Database (APD) to obtain information on all crit-
ically ill patients with both sepsis and AKI from 57 Australian
ICUs over a 5-year period. Our objectives were as follows: to
describe and compare the incidence and clinical characteris-
tics of critically ill patients admitted with sepsis, nonseptic AKI
and septic AKI; to describe and compare the severity of AKI
stratified by sepsis; and to describe and compare the clinical
outcomes of sepsis, nonseptic AKI and septic AKI.
Materials and methods
This was a retrospective analysis of prospectively collected
data. We interrogated the ANZICS APD for all adult (age ≥18
years) intensive care unit (ICU) admissions for a duration of 24
hours or longer associated with a primary diagnosis of sepsis
from 1 January 2000 to 31 December 2005. In the event of
multiple admissions, only the initial ICU admission was consid-
ered in order to avoid bias. For those patients who were read-
mitted within 72-hours after initial discharge, the readmission
was considered part of the initial index admission. The
ANZICS APD is a high quality clinical and research database
that routinely captures clinical, physiological and laboratory
data for all patients admitted to the ICU. Physiological and lab-
oratory data are only captured for the index 24 hours after ICU
admission. The database also captures both ICU and hospital
clinical outcome data. The ANZICS APD contains data from
more than 600,000 individual adult admissions to 135 ICUs
from 1987 to the present [23]. We selected only those ICUs
that had continuously contributed data to the APD during this
5-year period. This cohort included 57 ICUs (19 tertiary refer-
ral, 15 metropolitan, 12 regional/rural and 11 private
hospitals).
Operational definitions/identification of cases
The presence of AKI was assessed for within the first 24 hours
after admission (early AKI). AKI was classified according to the
RIFLE (risk of renal failure, injury to the kidney, failure of kidney
function, loss of kidney function and end-stage kidney disease)
criteria with a modification of the urine output criteria [24]. For
this study, the outcome RIFLE categories loss and end-stage
kidney disease were not evaluated. Although urine output was
described in 92.5% of all patients, only the cumulative 24-hour
output was available and no patient weights were described
[5]. Thus, we used a minor modification of the RIFLE urine out-
put criteria as previously described, assuming an average
patient weight of 70 kg and dividing patients into the following
categories: <35 ml/hour (risk), <21 ml/hour (injury) or <4 ml/
hour (failure). Baseline serum creatinine values were estimated
using the Modification of Diet in Renal Disease (MDRD) equa-
tion, as recommended by the Acute Dialysis Quality Initiative
(ADQI) Working Group (assuming a lower limit of normal
baseline glomerular filtration rate of 75 ml/minute) and similar
to previous studies [5,6]. For analysis, patients were assigned
to their worst RIFLE category according to either serum creat-
inine or urine output criteria. As data only for the first 24 hours
after admission are available, we use the term 'early' to
describe the septic AKI syndrome reported in this study. Sep-
sis was defined using consensus criteria [25,26].
Data collection
Standard demographic, clinical and physiological data were
retrieved. Demographic information included age, sex, and
dates and source of admission. Clinical data encompassed
primary diagnosis, surgical status, presence of co-morbidities
and need for mechanical ventilation. Physiological data
included Glasgow Coma Scale score, vital signs, arterial oxy-
gen tension (PaO2)/fraction of inspired oxygen (FiO2) ratio,
serum pH, serum sodium, potassium, bilirubin, haematocrit
and white cell count. Data on kidney function included serum
creatinine, urea and urine output [23]. Severity of illness was
assessed using the Acute Physiology and Chronic Health
Evaluation (APACHE) II, APACHE III and Simplified Acute
Physiology Score (SAPS) II systems [27,28]. Pre-existing co-
morbidities were defined by use of the chronic health evalua-
tion for APACHE II, APACHE III and SAPS II systems, as out-
lined in the ANZICS APD data dictionary [23].
Statistical analysis
Analysis was performed using Intercooled Stata (Stata Corp,
College Station, TX, USA). In the event of missing data values,
data were not replaced. Normally or near normally distributed
variables are reported as means with standard deviations andAvailable online http://ccforum.com/content/12/2/R47
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compared using Student's t-test, analysis of variance, or sim-
ple linear regression. Non-normally distributed continuous
data are reported as medians with interquartile ranges (IQRs)
and compared using Mann-Whitney U-test or Kruskal-Wallis
test. Categorical data were reported as proportions and com-
pared using Fisher's exact test. Multivariable logistic regres-
sion analysis was used to assess the association of septic AKI
with ICU and hospital mortality. A priori selected variables
included age, sex, co-morbidity, sepsis diagnosis, AKI diagno-
sis, need for mechanical ventilation, APACHE II score and hos-
pital site. Model fit was assessed by the goodness-of-fit test
and discrimination was assessed using the area under the
receiver operator characteristic curve. Data are presented as
odds ratios (ORs) with 95% confidence intervals (CIs). P <
0.05 was considered statistically significant for all
comparisons.
Results
In total, 120,123 patients were admitted to the 57 ICUs during
the 5-year study. These patients had a mean ± standard devi-
ation age of 61.7 ± 17.5 years, 59% were male, 28.6% had
co-morbid disease, and the mean ± standard deviation
APACHE II scores were 16.9 ± 7.7.
Sepsis
Sepsis was the primary admission diagnosis in 33,375
patients (estimated cumulative incidence of 27.8%). Septic
patients were generally younger (P  < 0.0001), were more
likely to be female (P < 0.0001), with a greater burden of co-
morbid disease (P < 0.0001) and higher severity of illness
scores (P < 0.0001), and were more likely to have been admit-
ted to the ICU for a medical indication (P < 0.0001), as com-
pared with nonseptic patients (Tables 1 and 2). Of those
patients with sepsis, 42.1% had concomitant AKI.
Early acute kidney injury
Early AKI was present in 43,395 patients (estimated cumula-
tive incidence 36.1%). Stratified by the RIFLE criteria, 16.3%
had risk, 13.6% had injury and 6.3% had failure. Compared
with non-AKI patients, those with AKI were older (P < 0.0001),
were more likely to be female (P < 0.0001), had more co-mor-
bid disease (P < 0.0001), had higher severity of illness scores
(P < 0.0001) and were more likely to be admitted to the ICU
for medical disease (Tables 1 and 2). Of those patients with
AKI, 32.4% had a primary diagnosis of sepsis.
Septic acute kidney injury
Septic AKI was present in 14,039 patients at ICU admission
(estimated cumulative incidence 11.7%). For septic AKI strat-
ified by RIFLE criteria, 38.5% had risk, 38.8% had injury and
22.7% had failure. The clinical characteristics, acute
physiology and laboratory parameters for septic AKI compared
with sepsis only and nonseptic AKI are shown in Tables 1 and
2. Patients with septic AKI had greater acuity of illness (P <
0.0001), lower blood pressure (P  < 0.0001), higher heart
rates (P < 0.0001), worse pulmonary function measures by
PaO2/FiO2  ratio (P  < 0.0001), greater acidaemia (P  <
0.0001) and higher white cell counts (P < 0.0001) when com-
pared with either sepsis with no AKI and nonseptic AKI. Septic
AKI was also associated with greater severity of AKI (RIFLE
category injury or failure) compared with nonseptic AKI (Table
3).
Mortality
Septic AKI was associated with a significantly higher crude
ICU (19.8% versus 13.4%; OR 1.60, 95% CI 1.5 to 1.7; P <
0.001) and in-hospital (29.7% versus 21.6%; OR 1.53, 95%
CI 1.46 to 1.60; P < 0.001) mortality when compared with
nonseptic AKI. Similarly, septic AKI, when compared with sep-
sis only, was associated with significantly higher mortality in
Table 1
Patient demographics at ICU admission stratified by admission diagnosis of sepsis and AKI
Characteristics None (n = 57,392) Sepsis, no AKI (n = 19,336) Nonseptic AKI (n = 29,356) Septic AKI (n = 14,039) P
Age (years) 58.6 (17.8) 57.4 (17.9) 68.1 (15.2) 66.7 (15.5) <0.0001
Male sex (%) 61.9 59.3 57.1 54.6 <0.0001
Co-morbid disease (%) 26.4 27.5 31.1 34 <0.0001
Cardiovascular 15.4 11.8 18.4 15.1 <0.0001
Respiratory 7.7 8.0 9.3 9.8 <0.0001
Liver 1.8 2.2 2.6 3.5 <0.0001
Immunocompromised 3.5 6.6 4.4 9.0 <0.0001
Haematologic malignancy 1.0 2.5 1.5 3.9 <0.0001
Metastatic cancer 2.8 3.7 2.4 3.5 0.57
Surgical (%) 62.1 37.9 49.0 16.3 <0.0001
Emergency 27.3 33.8 36.9 49.9 <0.0001
AKI, acute kidney injury; ICU, intensive care unit.Critical Care    Vol 12 No 2    Bagshaw et al.
Page 4 of 9
(page number not for citation purposes)
the ICU (19.8% versus 7.5%; OR 3.07, 95% CI 2.9 to 3.3; P
< 0.001) and in hospital (29.7% versus 12.6%; OR 2.93,
95% CI 2.8 to 3.1; P < 0.001; Figure 1 and Table 4). Septic
AKI, compared with nonseptic AKI, was consistently associ-
ated with higher ICU and hospital mortality across all strata of
RIFLE categories (Figure 2). In multivariable analysis, after
adjustment for co-variates, sepsis, nonseptic AKI and septic
AKI were all found to be significantly associated with higher
ICU and hospital mortality (Table 4).
Secondary outcomes
In survivors to ICU and hospital discharge, sepsis, nonseptic
AKI and septic AKI were all associated with progressively
longer durations of stay in both ICU and hospital (Table 5).
Similarly, septic AKI, as compared with nonseptic AKI, was
consistently associated with longer durations of stay in both
ICU and hospital across all strata of RIFLE categories (Figures
3a and 3b). In addition, those with septic AKI were found to be
less likely to be discharged home and more likely to be trans-
ferred to another acute care hospital or long-term rehabilitation
centre when compared with patients with nonseptic AKI, sep-
sis only, or neither (Table 5).
Discussion
We conducted a large multicentre epidemiological ICU study
of more than 14,000 cases of sepsis complicated by early AKI.
Our principal objectives were to describe the incidence,
clinical characteristics and outcomes associated with septic
AKI and to compare early septic AKI patients with critically ill
patients with nonseptic AKI, sepsis only and neither sepsis nor
AKI.
Table 2
Summary of acute physiology and laboratory parameters by sepsis and AKI
None 
(n = 57,392)
Sepsis, no AKI 
(n = 19,336)
Nonseptic AKI 
(n = 29,356)
Septic AKI 
(n = 14,039)
P
APACHE II score (mean [SD]) 14.4 (6.4) 15.4 (7.0) 20.0 (7.9) 22.3 (8.1) <0.0001
GCS score (median [IQR]) 15 (14–15) 15 (13–15) 15 (13–15) 15 (12–15) 0.001
Mean arterial pressure (mmHg; mean [SD]) 84.3 (26.9) 86.5 (27.7) 81.3 (28.2) 77.5 (28.3) <0.0001
Heart rate (beats/minute; mean [SD]) 91 (31) 96 (32) 96 (33) 104 (35) <0.0001
Respiratory rate (breaths/minute; mean [SD]) 18 (10) 20 (11) 20 (10) 23 (11) <0.0001
PaO2/FiO2 ratio (mean [SD]) 287 (154) 262 (145) 260 (153) 230 (140) <0.0001
PaCO2 (mmHg; mean [SD]) 42.7 (12.4) 42.5 (13.1) 43.2 (14.5) 42.0 (14.5) <0.0001
Temperature (°C; mean [SD]) 36.7 (1.5) 36.8 (1.6) 36.6 (1.6) 36.9 (1.7) <0.0001
Mechanical ventilation (%) 53.3 49.5 52.6 49.2 <0.0001
pH (mean [SD]) 7.35 (0.1) 7.35 (0.1) 7.30 (0.1) 7.29 (0.1) <0.0001
Bilirubin (mmol/l; median [IQR]) 12 (6–18) 12 (6–18) 13 (6–19) 14 (7–21) 0.0001
Albumin (g/l; mean [SD]) 28.2 (7.4) 27.8 (7.6) 26.2 (7.6) 25.1 (7.4) <0.0001
Haematocrit (%; median [IQR]) 0.33 (0.28–0.39) 0.34 (0.28–0.39) 0.31 (0.27–0.39) 0.32 (0.27–0.38) 0.0001
White cell count (× 109 cells/ml; mean [SD]) 13.4 (9.7) 14.2 (13.8) 15.0 (11.5) 16.8 (14.7) <0.0001
Potassium (mmol/l; mean [SD]) 4.2 (0.7) 4.1 (0.7) 4.5 (1.0) 4.4 (1.0) <0.0001
Creatinine (μmol/l; median [IQR]) 76 (60–90) 73 (57–90) 141 (113–200) 165 (124–254) 0.0001
Urea (mmol/l; median [IQR]) 5.3 (4–7) 5.6 (4–7.8) 10.4 (7.3–16.1) 13.2 (8.9–19.8) 0.0001
Urine output (l/24 hours; median [IQR]) 2.12 (1.54–2.97) 2.05 (1.50–2.98) 1.40 (0.68–2.28) 1.39 (0.66–2.30) 0.0001
APACHE, Acute Physiology and Chronic Health Evaluation; FiO2, fraction of inspired oxygen; GCS, Glasgow Coma Scale; IQR, interquartile 
range; PaCO2, arterial oxygen tension; PaO2, arterial oxygen tension; SD, standard deviation.
Table 3
Incidence of AKI stratified by RIFLE criteria and by an 
admission diagnosis of sepsis
RIFLE categorya Nonseptic 
(n = 86,748)
Septic 
(n = 33,375)
None (%) 66.2 57.9
Risk (%) 16.3 16.2
Injury (%) 12.6 16.3
Failure (%) 5.0 9.6
Any RIFLE category (%) 33.8 42.1
aClassification into RIFLE category based on fulfilling worst criteria 
for either serum creatinine or urine output. AKI, acute kidney injury; 
RIFLE, risk of renal failure, injury to the kidney, failure of kidney 
function, loss of kidney function and end-stage kidney diseaseAvailable online http://ccforum.com/content/12/2/R47
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First, we found that early septic AKI is common and present in
nearly 12% of all ICU admissions. Importantly, of those admit-
ted with a primary diagnosis of sepsis, 42% had concomitant
AKI. Similarly, for those with AKI, an estimated 32% had sep-
sis as a contributing factor. Second, our findings suggest that
septic AKI patients are clinically distinct and have features that
differentiate them from patients with nonseptic AKI.
Septic AKI patients are older and have more co-morbid dis-
ease. Septic AKI was more likely to be associated with medi-
cal admissions; however, if the admission was surgical, then
septic AKI was more likely to be associated with an emergency
surgical admission.
Septic AKI was also characterized by greater acuity of illness
as demonstrated by severity of illness scores and greater aber-
rancy in vital signs, markers of inflammation and blood
chemistry. Third, these distinguishing features of septic AKI
appeared to translate into relevant differences in clinical out-
comes when compared with nonseptic AKI. For example, sep-
tic AKI was associated with greater risks for both ICU and
hospital death. This was consistent across all strata of AKI
severity when stratified by RIFLE category. Likewise, septic
AKI contributed to significantly longer durations of stay in both
ICU and hospital.
These findings are largely consistent with and extend data
from prior investigations into septic AKI. Observational studies
have shown that the incidences of sepsis and AKI are increas-
ing [7,8,10,29,30]. Small single centre studies have found that
11% to 37% of all septic patients have concomitant AKI
[13,14,18]. The multicentre European Sepsis Occurrence in
Acutely Ill Patients (SOAP) study found that 51% of septic
patients developed AKI, defined by a Sequential Organ Failure
Assessment score above 2 (serum creatinine >177 μmol/l)
[17]. More recently, in a 1-day point prevalence survey for
severe sepsis/septic shock from 454 ICUs in Germany,
Oppert and coworkers [16] reported concomitant AKI in
41.4% of septic patients. Likewise, two large multicentre
observational studies of critically ill patients with AKI [12,15]
found sepsis to be a contributing factor in 46% to 48% of epi-
sodes of AKI. However, these studies are somewhat limited by
their inclusion of only septic patients or only AKI patients, and
therefore they provide a potentially biased comparison.
Our data are largely comparable, but we can further illustrate
the overall high burden of septic AKI in relation to all ICU
admissions (11.7% overall). Moreover, we can show both the
high incidence of early AKI accompanying sepsis (42.1%) and
sepsis contributing to early AKI (32.4%). In addition, our study
is the first to date to compare clinical characteristics and out-
comes between septic AKI and nonseptic AKI, sepsis only,
and a control cohort with neither sepsis nor AKI. We believe
that the generalizability of our study is further strengthened by
incorporating data from multiple centres and across a range of
hospital types. A reasonable inference from these accumu-
lated data is that sepsis has clearly surfaced as the most sig-
nificant predictor of AKI in critically ill patients and that the
occurrence of septic AKI is likely to increase further.
The findings of our study further support the concept that dis-
criminating septic and nonseptic AKI may have clinical impor-
tance. In other words, septic AKI may differ from AKI induced
by other factors and from sepsis not complicated by AKI [19].
The mechanisms that account for these differences remain
speculative, but they may relate to the physiological and
immune consequences of either sepsis or AKI alone or of their
additive and complex interplay. Studies have generally found
septic AKI to be associated with older age, greater co-morbid
Figure 1
Crude ICU and hospital mortality stratified by subgroups Crude ICU and hospital mortality stratified by subgroups. The sub-
groups of patients were control, sepsis, acute kidney injury (AKI) and 
septic AKI. ICU, intensive care unit.
Figure 2
Crude hospital mortality for septic and non-septic AKI stratified by  RIFLE category Crude hospital mortality for septic and non-septic AKI stratified by 
RIFLE category. For each comparison of nonseptic versus septic acute 
kidney injury (AKI), P < 0.0001. RIFLE, risk of renal failure, injury to the 
kidney, failure of kidney function, loss of kidney function and end-stage 
kidney disease.Critical Care    Vol 12 No 2    Bagshaw et al.
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disease, nonsurgical disease, greater severity of illness, more
aberrancy in haemodynamic parameters, greater need for
mechanical ventilation and vasopressor support, and greater
disturbances in inflammation, haematology, and acid-base
homeostasis [12,14-16,18]. Two studies [12,13] have also
found septic AKI to be associated with higher central venous
filling pressures and lower urine output when compared with
nonseptic AKI. Moreover, the concept that septic AKI may
have a distinct pathophysiology is supported not only by
experimental data and evidence from small clinical studies
[9,20,31-34] but also by epidemiological data showing 'dose-
response' trends in incidence rates and outcomes for septic
AKI by either severity of sepsis or AKI.
Rangel-Frausto and coworkers [11] were the first to show how
the incidence of AKI, defined by need for renal replacement
therapy, increased significantly according to whether patients
had sepsis (24%), severe sepsis (39%), or septic shock
(89%). Lopes and colleagues [14] showed that the rate of AKI
increased from 29% to 51% when categorized from severe
sepsis to septic shock. This study also found that the relative
severity of AKI in septic shock was worse, with a greater pro-
portion classified RIFLE category failure when compared with
those with severe sepsis (64% versus 36%). We contend that
the differences in pathophysiology between AKI due to sepsis
and other aetiologies (ischaemia, toxin, cardiopulmonary
bypass) may have important clinical implications for detection
of early kidney injury, changes to kidney function and trajectory
of AKI, along with the application of potential interventions to
attenuate injury and promote kidney recovery.
Furthermore, all prior studies describing septic AKI have con-
sistently concluded that septic AKI contributes to markedly
higher mortality than either nonseptic AKI or sepsis alone [12-
16,18]. These studies are in general agreement with our find-
ings. Moreover, we were also able to show a 'dose-response'
increase in mortality with greater severity of AKI by RIFLE cat-
egory in sepsis compared with nonsepsis (Figure 2). We con-
tend this also provides further support for the clinical
relevance and robustness of the RIFLE classification system.
Table 4
Summary of crude and co-variate adjusted odds ratios for mortality for septic AKI admitted to ICU
Category ICU mortality Hospital mortality
Crude OR (95% CI) Adjusted OR (95% CI)a Crude OR (95% CI) Adjusted OR (95% CI)b
None 1.0 1.0 1.0 1.0
Sepsis 1.89 (1.77–2.03) 1.47 (1.36–1.60) 1.75 (1.65–1.84) 1.40 (1.31–1.49)
Nonseptic AKI 3.64 (3.45–3.84) 1.53 (1.44–1.63) 3.36 (3.22–3.50) 1.43 (1.36–1.50)
Septic AKI 5.81 (5.48–6.17) 1.69 (1.57–1.82) 5.12 (4.89–5.38) 1.54 (1.45–1.64)
aArea under the receiver operator characteristic (AuROC) 0.86, goodness-of-fit P = 1.0. bAuROC 0.84, goodness-of-fit P = 1.0. AKI, acute kidney 
injury; CI, confidence interval; ICU, intensive care unit; OR, odds ratio; RIFLE, risk of renal failure, injury to the kidney, failure of kidney function, loss 
of kidney function and end-stage kidney disease
Figure 3
ICU and hospital length of stay ICU and hospital length of stay. (a) Intensive care unit (ICU) length of stay for acute kidney injury (AKI) patients stratified by sepsis and RIFLE cate-
gory. For each comparison of nonseptic versus septic AKI, P < 0.0001. (b) Hospital length of stay for AKI patients stratified by sepsis and RIFLE 
category. For each comparison of nonseptic versus septic AKI, P < 0.0001. RIFLE, risk of renal failure, injury to the kidney, failure of kidney function, 
loss of kidney function and end-stage kidney disease.Available online http://ccforum.com/content/12/2/R47
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Similarly, Neveu and coworkers [15] previously found a near
linear increase in mortality for AKI when categorized as non-
septic or associated with either sepsis syndrome or septic
shock. This 'dose-response' trend for septic AKI was likewise
apparent when evaluating durations of stay in ICU and hospital
for survivors by severity of AKI. These data, within the context
of prior investigations, logically imply that septic AKI may be
distinct, may behave differently and may independently por-
tend a worse prognosis. We contend that these findings have
relevance for the management of the septic patient with AKI.
Accordingly, a diagnosis of septic AKI may deserve consider-
ation for separate stratification of randomization and a priori
identification for subgroup analysis when applying therapeutic
strategies and/or designing future research investigations of
the treatment of AKI.
There are limitations to our study. First, we estimated the
occurrence of AKI at or within the first 24 hours of ICU
admission only. Thus, we are unable to comment on the occur-
rence and outcomes for patients with ICU-acquired AKI or
sepsis, which may be associated with a worse outcome [35].
We recognize this may result in an underestimate of the true
cumulative incidence of septic AKI. However, we believe that
our data provide an important approximation of the disease
burden associated with septic AKI. Second, we were unable
to determine baseline creatinine values or the prevalence of
chronic kidney disease with the exception of those with end-
stage renal disease. However, this problem is not uncommon.
We thus calculated an estimate of baseline function by use of
the MDRD equation as recommended by the ADQI group
[24]. Nonetheless, these factors may contribute to a misclas-
sification of some patients and result in an overestimate of the
occurrence of septic AKI. Third, we were unable to describe
changes over time in kidney function or transition between
RIFLE criteria. Finally, we were unable to describe the
association of initial RIFLE category to other clinical outcomes
such as the proportion of patients receiving renal replacement
therapy, long-term survival, or renal recovery beyond hospital
discharge. Thus, whether septic AKI contributes to down-
stream morbidity and mortality conditional on hospital survival
remains likely but unknown.
In summary, we conducted a multicentre observational study
of the incidence and outcomes of septic AKI in a large hetero-
geneous cohort of critically ill patients. We showed that septic
AKI is common and is associated with a higher burden of ill-
ness and greater abnormalities in acute physiology and labo-
ratory parameters compared with either nonseptic AKI or
sepsis alone. We have further shown that septic AKI confers
an important and independent increase in risk for hospital
death that exceeds that of either nonseptic AKI or sepsis
alone. In survivors, septic AKI was also associated with pro-
longed ICU and hospital stays, and a greater likelihood of dis-
charge to rehabilitation or another acute care facility. We
contend that these data support the emerging concept that
septic AKI may represent a unique pathophysiological condi-
tion. Moreover, we believe that future investigations should
consider these differences in AKI pathophysiology when
applying potential therapeutic interventions.
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Table 5
Secondary outcomes in ICU patients stratified by sepsis and AKI
Clinical outcome None 
(n = 57,392)
Sepsis, no AKI 
(n = 19,336)
Nonseptic AKI 
(n = 29,356)
Septic AKI 
(n = 14,039)
P
ICU length of stay (days)
Dead (median [IQR]) 3.9 (2.1–8.1) 4.6 (2.3–9.5) 3.7 (1.9–7.7) 3.9 (2.0–8.8) 0.0001
Alive (median [IQR]) 2.1 (1.6–3.8) 2.4 (1.6–4.8) 2.8 (1.8–5.2) 3.8 (2.0–7.6) 0.0001
Hospital length of stay (days)
Dead (median [IQR]) 10.2 (4.4–23.0) 10.6 (4.8–23.0) 9.0 (3.7–20.2) 9.5 (3.7–20.9) 0.0001
Alive (median [IQR]) 10.2 (6.9–18.2) 11.8 (6.7–22.7) 13.9 (8.1–25.1) 16.7 (9.5–30.9) 0.0001
Discharge location of survivors (%)
Home 86.7 81 79.9 75.6 <0.0001
Transfer to other hospital 4.5 5.9 7.3 8.5 <0.0001
Rehabilitation/long-term care 8.8 13.1 12.8 15.9 <0.0001
AKI, acute kidney injury; ICU, intensive care unit; IQR, interquartile range.Critical Care    Vol 12 No 2    Bagshaw et al.
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